Stocksigma LogoStocksigma Logo

Asston Pharmaceuticals Reports H1 FY27 Financial Results

Asston Pharmaceuticals reported revenue from operations of ₹1,526.58 lakhs for the half-year ended 30th Sep'26, compared to ₹1,541.59 lakhs in the year-ago

Asston Pharmaceuticals Reports H1 FY27 Financial Results

Asston Pharmaceuticals Ltd · Financial Result · 12 Nov 2026, 11:46 pm

Asston Pharmaceuticals Reports H1 FY27 Financial Results Asston Pharmaceuticals reported revenue from operations of ₹1,526.58 lakhs for the half-year ended 30th Sep'26, compared to ₹1,541.59 lakhs in the year-ago period ended 30th Sep'25 and ₹1,005.29 lakhs in H2 FY26. Net profit stood at ₹327.37 lakhs, down slightly from ₹338.21 lakhs YoY but up significantly from ₹48.30 lakhs in H2 FY26, with an unannualized basic and diluted EPS of ₹3.70. The company raised ₹2,771.58 lakhs via a preferential equity share allotment, expanding paid-up capital to ₹1,092.28 lakhs.

Original exchange filing (PDF)

More announcements from Asston Pharmaceuticals Ltd

All Asston Pharmaceuticals Ltd announcements